Home
Online Journal
Media Info
Event list
Partners
Advisory board
About us
Contact
Jobs
Web Advertisement
Biotech
Clinical Research
Clusters
Food & Health
Law & Insurance
Medtech
Nano & Biomaterials
Pharma
Science Parks/org
Webcast
Press Releases
Markets & Trends
Welcome to the
European Life Science Journal for international business
Get inspired by the entrepreneurs leading the way of tomorrow´s life science businesses !
Biotech
2012-02-10
(0 kommentarer)
Adenovir Pharma: Innovation for eye infections
Epidemic keratoconjunctivitis (EKC) is a highly contagious eye infection caused by a number of different adenoviruses. Symptoms include conjunctivitis, keratitis, tearing, pain and discomfort, and the development of pseudomembranes. In around 60% of patients, the infection spreads to the second eye, and 20-50% of patients develop corneal opacities that can cause visual problems for weeks, month...
2011-08-18
(0 kommentarer)
China placing priority on biotechnology
China will spend 2 trillion yuan ($308.5 billion) on science and technology, making biotechnology a major priority, in the next five years, Chinese State Councilor Liu Yandong said at the ong...
2011-06-01
(0 kommentarer)
Stem cell technology used in unique surgery in Gothenburg
Prof. Michael Olausson, responsible for the unique surgery at Sahlgrenska University Hospital.Photo: Björn Larsson RosvallFor the first time ever in the world, researchers at the Sahlgrenska ...
2011-04-01
(0 kommentarer)
Nordiag and Molzym enter into first sepsis agreement
Sepsis is one of the leading cause of death in hospitals world-wide. On March 17, it was announced that Molzym has entered into an agreement with Seegene for delivery of reagents based on their mol...
2011-03-23
(0 kommentarer)
Vironova leads Flucure project
TEM image of influenza virus The Swedish biotech company developing novel antiviral therapeutics and virus diagnostics, Vironova, leads a new influenza drug development programme with EU fundi...
2011-01-13
(0 kommentarer)
Lorus Therapeutics Enrolls First Patient in Phase I Clinical Study of Anticancer Drug LOR-253
TORONTO, ONTARIO--(Marketwire - Jan. 13, 2011) - Lorus Therapeutics Inc. (TSX:LOR)(OTCBB:LRUSF) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development ...
2010-11-09
(0 kommentarer)
Cutting costs must not hamper innovation
Biotech companies worldwide reported a profit in 2009 for the first time since 1985 as revenues increased and spending on R&D was cut.ECONOMIC OUTLOOK: A report recently published by Erns...
2010-11-08
(0 kommentarer)
Making personal medicine a reality
BlackBiostarted as a new entity, based upon a revolutionary development achieved by itsfounding team, by converting the until now little known Pyrosequencingtechnology into the spotlight for ...
2010-10-13
(0 kommentarer)
Spanish biotech industry exceeds EUR 30 billion in revenue
The Spanish BioindustryAssociation’s annual report shows that investments in R&D have been doubledin three years, up to UER 460 million in 2008 and that internationalisation is,for the fi...
2010-08-24
(0 kommentarer)
Higher quality and efficient bioanalytical service at Quotient Bioresearch
Quotient Bioresearch is a fast growing contract research organisation that brings together well-known specialists in radiochemistry, metabolism, bioanalysis and biomarkers, early phase clinical res...
2010-04-01
(0 kommentarer)
Consolidated CRO connects east and west
SBW Ltd is well-positioned to handle the restructuring of the pharma industry, where both India and China are becoming all the more important destinations for pharma research and development....
Banners
Bio IT
Bio material
Bio Suppliers / Distributors
Bio Suppliers / Manufacturers
Consulting
CRO
Diagnostics
Drug Design
Events
Food Health
Genomics
Health care
Hospitals
Intellectual
Investors
Laboratories
Nanotech
Organisations
Pharma
Science Parks
Services
Technology centres
Universities
Contract Manufacturing